Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Latest Articles
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • Topics
    • Applied and Environmental Science
    • Clinical Science and Epidemiology
    • Ecological and Evolutionary Science
    • Host-Microbe Biology
    • Molecular Biology and Physiology
    • Therapeutics and Prevention
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About mBio
    • Editor in Chief
    • Board of Editors
    • AAM Fellows
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
mBio
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Latest Articles
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • Topics
    • Applied and Environmental Science
    • Clinical Science and Epidemiology
    • Ecological and Evolutionary Science
    • Host-Microbe Biology
    • Molecular Biology and Physiology
    • Therapeutics and Prevention
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About mBio
    • Editor in Chief
    • Board of Editors
    • AAM Fellows
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
Minireview

Picornaviruses and Apoptosis: Subversion of Cell Death

Sarah N. Croft, Erin J. Walker, Reena Ghildyal
Diane E. Griffin, Invited Editor, R. John Collier, Editor
Sarah N. Croft
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erin J. Walker
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Erin J. Walker
Reena Ghildyal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Diane E. Griffin
Johns Hopkins Bloomberg School of Public Health
Roles: Invited Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. John Collier
Harvard Medical School
Roles: Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/mBio.01009-17
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Infected cells can undergo apoptosis as a protective response to viral infection, thereby limiting viral infection. As viruses require a viable cell for replication, the death of the cell limits cellular functions that are required for virus replication and propagation. Picornaviruses are single-stranded RNA viruses that modify the host cell apoptotic response, probably in order to promote viral replication, largely as a function of the viral proteases 2A, 3C, and 3CD. These proteases are essential for viral polyprotein processing and also cleave cellular proteins. Picornavirus proteases cleave proapoptotic adaptor proteins, resulting in downregulation of apoptosis. Picornavirus proteases also cleave nucleoporins, disrupting the orchestrated manner in which signaling pathways use active nucleocytoplasmic trafficking, including those involved in apoptosis. In addition to viral proteases, the transmembrane 2B protein alters intracellular ion signaling, which may also modulate apoptosis. Overall, picornaviruses, via the action of virally encoded proteins, exercise intricate control over and subvert cell death pathways, specifically apoptosis, thereby allowing viral replication to continue.

INTRODUCTION

Picornaviruses can selectively alter cellular pathways in order to promote viral replication, mostly through the action of viral proteases, including modulation of proapoptotic factors or processes. Control of cell death processes is vital to viral replication, which requires a viable cell; however, release of the virus can be inhibited through apoptosis inhibitors (1), and thus, a precise control over pro- and antiapoptotic processes is essential to Picornavirus replication. As such, control or modulation of apoptotic processes is favorable to picornaviruses, and this minireview will specifically focus on the modifications of cellular processes by picornaviruses that lead to downregulation of apoptosis. The direct cleavage of caspases (2), disruption of nuclear-cytoplasmic trafficking (3, 4), relocalization of proapoptotic proteins (5, 6), and cleavage of essential apoptotic adaptor proteins (7, 8) have all been shown to occur as a result of action of Picornavirus protease activity and together suggest mechanisms by which picornaviruses can alter host cell apoptotic death pathways.

PICORNAVIRUSES

Picornaviruses cause a wide variety of diseases in humans. Within the respiratory system, human rhinovirus (HRV) causes common colds and asthma (9), within the nervous system, poliovirus (PV) causes poliomyelitis (10), and within the liver, hepatitis A virus (HAV) causes hepatitis (11). Picornaviruses are small, nonenveloped viruses that contain a single strand of positive-sense RNA (ssRNA) (12). The Picornavirus replication cycle is initiated by attachment of the virus to the host cell receptor, followed by internalization and uncoating of the virus genome (13). The single open reading frame of the genome is translated into a large polyprotein that undergoes posttranslational processing (cis and trans cleavage) by the virally encoded proteases to yield mature, structural or nonstructural proteins (14). The mature proteins then participate in transcription and replication of the RNA genome and assembly and release of the virus. The viral proteases not only participate in the maturation of the viral proteins but also act against cellular factors, resulting in host cell shutoff and increased virus replication. Cell death is an important cellular mechanism to limit viral spread, and viruses, including picornaviruses, have evolved to inhibit cell death. In this minireview, we aim to review and discuss current literature on Picornavirus modulation of cell death pathways with a view to integrating diverse studies to form a rational informed model of Picornavirus disruption of apoptotic pathways.

APOPTOSIS

Cell death can occur as a result of many stimuli with the type of stimulus determining the type of cell death. Apoptosis is a process of selective, controlled cell death (15–17), which utilizes a cascade of signaling proteins after the activation of a death signal. The induction of apoptosis, discussed below in the context of viral infection, can occur extrinsically, in response to nonself or external stimuli, or intrinsically, in response to inherent, cellular abnormalities (17). The extrinsic and intrinsic apoptosis pathways converge to cleave and activate procaspase-3 to derive caspase 3, which is termed an executioner caspase. Caspase 3 subsequently activates or inactivates substrates to facilitate the morphological changes that are associated with apoptotic cell death, such as chromatin condensation, cell shrinkage, nuclear and plasma membrane blebbing (15, 16, 18). The removal of the resulting apoptotic bodies occurs through phagocytic engulfment ensuring that the process avoids an inflammatory response (15–17). Apoptotic bodies can provide a means for viruses to evade immune responses (19); however, the induction of apoptosis has been shown to reduce viral titer (20). Studies have shown that it is not the complete inhibition of apoptosis that is beneficial to viral replication, but timely control that results in apoptotic delay, then induction (2, 21).

Apoptotic death in response to viral infection can commonly proceed via the extrinsic pathway in response to external stimuli or via the intrinsic pathway in response to internal stress signals (Fig. 1). Upon the recognition of foreign molecular patterns by death signaling proteins (e.g., Fas [22]) [Fig. 1(i)], adaptor proteins are recruited, and death signaling complexes form (22, 23) at the mitochondria or in the cytoplasm. The exact composition of death signaling complexes will vary [Fig. 1(ii)]; however, activation results in the recruitment of procaspase-8 [Fig. 1(iii)], which then undergoes autocatalysis to form active caspase 8 [Fig. 1(iv)] (22). Caspase 8 cleaves procaspase-3 into the active caspase 3 [Fig. 1(v)] (24) that causes subsequent characteristic apoptotic changes (24–26) [Fig. 1(vi) and (vii)].

FIG 1 
  • Open in new tab
  • Download powerpoint
FIG 1 

Antiviral apoptotic pathways. Induction of the extrinsic apoptotic pathway (pink shaded area) is initiated by the binding of a picornavirus-associated molecular pattern to a pathogen receptor (i), e.g., dsRNA to TLR3, MDA-5, or RIG-I. Subsequently, adaptor proteins TRIF, FADD, RIPK1, and TRADD are recruited directly to the receptor or via IPS-1 in the case of RIG-I and MDA-5 (ii), forming the death receptor complexes. Procaspase-8 is recruited to the death receptor complexes (iii) and undergoes autocatalysis (iv) to active caspase 8. Caspase 8 then cleaves and activates caspase 3 (v), which translocates to the nucleus (vi) and activates proteins to execute apoptotic morphological changes (vii). The cleavage of Bid by caspase 8 (xii) produces truncated Bid (tBid), which induces Bax and Bak (xiii) to insert into the outer mitochondrial membrane, allowing cytochrome c to translocate into the cytoplasm (ix). APAF-1 binds cytochrome c (x), and procaspase-9 is recruited to the complex, undergoing autocatalysis to caspase 9 (xi). Caspase 9 cleaves procaspase-3 to caspase 3 (v), which translocates to the nucleus (vi) and activates proteins to execute apoptotic morphological changes (vii). TBK1 and IKKε can also be recruited to IPS-1 (xv), and once recruited, phosphorylate IRF-3. Phospho-IRF-3 translocates to the outer mitochondrial membrane (xvi), complexing with Bax to form a pore (viii), releasing cytochrome c into the cytoplasm (ix) and inducing a procaspase-9-dependent apoptotic signaling cascade. Abbreviations: TLR3, Toll-like receptor 3; TRIF, TIR domain-containing adaptor-inducing beta interferon; RIPK1, receptor-interacting protein kinase 1; FADD, Fas-associated protein with death domain; TRADD, tumor necrosis factor receptor type 1-associated death domain protein; RIG-I, retinoic acid-inducible gene 1; MDA-5, melanoma differentiation-associated protein 5; IPS-1, interferon-β promoter stimulator 1; TBK1, TANK-binding kinase 1; IKKε, inhibitor of nuclear factor κB kinase epsilon; IRF-3, interferon regulatory factor 3; Bak, Bcl-2 homologous antagonist/killer; Bax, Bcl-2-like protein 4; Bid, BH3-interacting-domain death agonist; tBid, truncated Bid; APAF-1, apoptotic protease activating factor 1.

TOLL-LIKE RECEPTORS IN APOPTOSIS

Toll-like receptors (TLRs) are specialized, cellular sensors that recognize pathogen-associated molecular patterns, with Toll-like receptor 3 (TLR-3) recognizing cytoplasmic double-stranded RNA (dsRNA), a picornaviral replication intermediate (23, 27) (Fig. 1). The binding of dsRNA to TLR-3 induces the formation of a TLR-3 homodimer, allowing exposure of the Toll–IL-1 receptor (TIR) domain (28). TIR domain-containing adaptor-inducing beta interferon (TRIF) binds to TLR-3. TRIF is essential for downstream nuclear factor κB (NF-κB), interferon regulatory factor 3 (IRF-3), and beta interferon (IFN-β) activation (29). The presence of a dominant-negative form of TRIF abolishes NF-κB signaling from TLR-2, -3, -4, and -7 (29), suggesting that it is crucial for a large portion of TLR signaling. Overexpression of TRIF induces apoptosis (29), dependent on its C-terminal domain, between amino acids 532 to 712 (29). TRIF-induced apoptosis relies on functional FADD (Fas-associated protein with death domain) and caspase 8, linking the sensing of dsRNA to apoptosis activation (29, 30) [Fig. 1(i) to (iv)], although other studies have reported that FADD depletion does not prevent TLR-3-induced apoptosis (28). Also essential to this pathway is RIPK1 (28), which associates with the C-terminal region of TRIF (30) as well as FADD and caspase 8 (29). The interaction between TRIF and RIPK1 occurs within homologous RIP homotypic interaction motif (RHIM) domains in both proteins, being mapped to the C-terminal region of TRIF (30) (see Fig. 4A). Mutation in the RHIM domain in TRIF abrogated TRIF-induced apoptosis, indicating that TLR-3-dependent apoptosis proceeds along a TRIF-RIPK1-FADD-caspase 8 axis (29, 30). RIPK1 can commit the cell to multiple cell death pathways; however, the RIPK1-induced cell death following TLR-3 activation was confirmed to be apoptotic and not necrotic (28).

VIRAL RNA SENSORS IN APOPTOSIS

The activation of either RIG-I (retinoic acid-inducible gene 1) or MDA-5 (melanoma differentiation-associated protein 5), cytosolic 5′-triphosphate RNA, or long dsRNA helicase receptors results in each receptor associating via homologous caspase recruitment domains (CARDs) to a mitochondrion-bound adaptor protein, IFN-β promoter stimulator-1 (IPS-1), from which multiple biochemical pathways can be induced (Fig. 1). Activated IPS-1 recruits IKKε (inhibitor of nuclear factor κB kinase epsilon) and TBK1 [Fig. 1(xv)], which results in the subsequent phosphorylation and dimerization of IRF-3 (31). IRF-3 homodimers can then translocate either to the nucleus, where they induce the expression of IFN-β or complexes with Bax (32) and translocate to the mitochondrial membrane [Fig. 1(xvi)], leading to the formation of a pore and induction of apoptosis. IPS-1-dependent IRF-3 activation has been shown to upregulate the expression of proapoptotic Bcl-2 proteins (discussed later within this minireview) (33), activate proapoptotic BH3 domain-containing proteins (34), and display a mitochondrial localization-dependent ability, leading to the activation of caspase 9 [Fig. 1(x) and (xi)] (35).

Additionally, IPS-1 activation can result in the formation of a complex that contains IPS-1, FADD, caspase 8, and RIPK1 (36) [Fig. 1(ii)]. The downstream effect of this complex relies on caspase 8-dependent cleavage of RIPK1 (36) at aspartate 324 which also acts to negatively regulate the activation of IRF-3 (36). The association of caspase 8 and RIPK1 to the IPS-1/RIG-I/MDA-5 complex induces activation of the apoptotic pathway (37).

Recent work has shown that IPS-1-induced apoptosis proceeds along an IPS-1/RIPK1/caspase 8 axis, independent of any IFN response or intrinsic apoptosis pathway (36, 38). Furthermore, IPS-1 and caspase 8 have been shown to be essential in anoikis, cell detachment due to apoptosis (39) through the adaptor protein DAP3, which is also essential for the recruitment of FADD to other apoptosis-inducing proteins (40); however, further research is needed to confirm the association of DAP3 in dsRNA/IPS-1-induced apoptosis.

Protein kinase RNA-activated (PKR) is a dsRNA sensor important for host responses in Picornavirus infection. PKR exists as a latent single molecule; however, the binding of dsRNA to two PKR molecules increases their proximity, thus inducing autophosphorylation and activation (41). The active kinase can activate p53 and NF-κB and has been shown to phosphorylate eukaryotic initiation factor 2a (eIF2a), inactivating it. The inactive eIF2a then acts as a competitive inhibitor of eIF2B, resulting in shutdown of protein synthesis (41, 42). The phosphorylated form of eIF2a has been shown to induce apoptosis through translational control, rather than complete translational shutdown (43, 44). Notably, eIF2a induces the downregulation of translation of antiapoptotic genes and promotes the expression of proapoptotic genes such as Fas, FasL (extrinsic apoptosis pathway), and p53 (intrinsic apoptosis pathway) as reviewed by Gil and Esteban (45). However, the activated apoptotic pathway induced after PKR activation can also proceed in a FADD- and caspase 8-dependent manner in response to viral infection (46) with a role for IPS-1 in the induction of PKR-induced apoptosis (47). Thus, PKR is hypothesized to, like RIG-I and MDA-5, bind and require IPS-1 for downstream signaling to caspase 8, which involves the formation of a complex with FADD, caspase 8, and the caspase 8-generated cleaved RIPK1 fragment, to promote apoptosis.

INTRINSIC APOPTOSIS

An apoptotic death signal can also be triggered in response to disruption to an internal cellular balance or process such as calcium ion balance disruption (discussed further in this minireview), DNA mutations, or mitochondrial dysfunction [Fig. 1(viii)]. Regardless of stimuli, critical to the intrinsic apoptosis pathway is loss in mitochondrial outer membrane permeability via membrane potential changes or the formation of a pore complex (48). The formation of the pore complex is dependent on the balance between pro- and antiapoptotic Bcl-2 family member proteins as reviewed in reference 49. The antiapoptotic Bcl-2 proteins (for example, Bcl-2 and Bcl-XL) interact with proapoptotic Bcl-2 proteins and act as negative regulators of apoptosis. Two classes of proapoptotic Bcl-2 proteins have been identified: those that act as initiator proteins (for example, Bim, truncated Bid [tBid], and Bad) and those that form the pore within the outer mitochondrial membrane (for example, Bak and Bax). The oligomerization of Bcl-2 proteins on the mitochondrial membrane forms a pore and allows proapoptotic factors into the cytoplasm. Cytochrome c is released within the cytoplasm (Fig. 1(ix)) where it complexes with apoptotic peptidase-activating factor 1 (APAF-1) [Fig. 1(x)] and recruits procaspase-9, inducing procaspase-9 autocatalysis and activation [Fig. 1(xi)], which in turn activates caspase 3 [Fig. 1(v)] (50).

EXTRINSIC AND INTRINSIC APOPTOSIS CROSS TALK

Importantly, there is interplay between the intrinsic and extrinsic pathways, with caspase 8 cleaving a Bcl-2 protein, Bid [Fig. 1(xii)]. Truncated Bid (tBid) then activates other Bcl-2 proteins (Bax and Bak) (51) [Fig. 1(xiii)], resulting in the formation of a pore on the outer mitochondrial membrane [Fig. 1(viii)] and inducing the intrinsic apoptosis pathway (51, 52). Furthermore, mitochondrion-anchored death signaling adaptor proteins have been implicated in response to Picornavirus infection that, when activated, can lead to caspase 8 activation {extrinsic apoptosis [Fig. 1(iii) and (iv), pink shaded area]} or the formation of a mitochondrial pore {intrinsic apoptosis [Fig. 1(xv) and (xvi), green shaded area} (34, 36).

DISRUPTION OF APOPTOTIC PATHWAYS BY PICORNAVIRUSES

Caspases.An early study by Belov et al. in 2003 showed that cells infected with poliovirus (PV) did not display apoptotic morphological changes (notably, DNA degradation and caspase 3 cleavage) (2). In contrast, cells that were subject to PV infection and viral (RNA replication) inhibitor guanidine hydrochloride (G-HCl) treatment underwent apoptosis as measured by characteristic DNA degradation (2). Without caspase 3, cells (in response to PV plus G-HCl) did not undergo apoptosis, implicating caspase 3 as the executioner of PV-induced apoptosis. Together these results suggest that apoptosis is induced in response to PV infection but active PV infection is able to inhibit apoptosis progression. PV infection resulted in an efflux of cytochrome c from the mitochondria into the cytoplasm (2), which should induce apoptosis (53). PV infection also resulted in the aberrant processing of procaspase-9 that probably contributes to the suppression of apoptosis (2) (Fig. 2A). Although it is not known whether a viral protease is responsible for the aberrant processing of procaspase-9 and there is no further research on this topic, this is a clear example of a picornavirus (either directly or indirectly) targeting caspase activity and altering apoptotic cell death pathways.

FIG 2 
  • Open in new tab
  • Download powerpoint
FIG 2 

Effects of picornavirus infections on intrinsic apoptosis pathways. (A) Caspase 9-dependent intrinsic apoptosis is initiated by the release of mitochondrial cytochrome c into the cytoplasm as described in the legend to Fig. 1. Procaspase-9 is cleaved in PV infection (indicated in red), resulting in a lack of function and inability to activate caspase 3, thus inhibiting intrinsic apoptosis. (B) The abrupt release of Ca2+ from the endoplasmic reticulum (ER) is a protective response following ER stress. The released Ca2+ is taken up into the mitochondrial matrix via RyR and IP3R channels. Increase of Ca2+ above a threshold level in the mitochondrial matrix induces an increase in mitochondrial membrane permeability, allowing the cytoplasmic release of cytochrome c, inducing intrinsic apoptosis. Picornaviral 2B protein inserts into the ER, forming an ion channel (indicated in red), allowing Ca2+ to leak into the cytoplasm, and decreasing the amount of Ca2+ available to translocate to the mitochondria, thus inhibiting intrinsic apoptosis. (C) RIG-I and MDA-5, when activated, associate with IPS-1 and recruit TBK1 and IKKε into a death receptor complex at the mitochondria. TBK1 and IKKε act by phosphorylating IRF-3 dimers which then induce a pore in the mitochondrial membrane, allowing release of cytochrome c into the cytoplasm, inducing intrinsic apoptosis. RIG-I, MDA-5, and IPS-1 are cleaved during infection (indicated in red) by several picornaviruses, inhibiting intrinsic apoptosis. P, phosphate; EchoV, echovirus.

Disruption of calcium ion signaling.There are multiple pathways that link the endoplasmic reticulum (ER), which is a calcium ion (Ca2+) storage site (54), to the induction of apoptosis. One mechanism of apoptosis induction is the sudden release of Ca2+ from the ER lumen into the cytoplasm of a cell (Fig. 2B) (55). The abrupt release of Ca2+ from the ER acts as a signaling mechanism following ER stress in order to protect the cell or organism from detrimental changes in Ca2+ or the misfolding or accumulation of proteins within the ER (54). The released Ca2+ is taken up into the mitochondrial matrix; this translocation can occur through electrophoretic mechanisms but predominantly occurs through microdomains (points of contact between the ER and the mitochondria) (54, 55) (Fig. 2B). Ca2+ release from the ER is dependent on the Ca2+ efflux through inositol 1,4,5-triphosphate receptor (IP3R) and ryanodine receptor (RyR) channels (56). Increase of Ca2+ concentration above threshold within the mitochondrial matrix then induces an increase in mitochondrial membrane permeability through the voltage-dependent anion channel (VDAC) in the outer mitochondrial membrane within the permeability transition pore complex (PTPC) (54, 55). This increase of permeability allows the cytoplasmic movement of mitochondrial proapoptotic proteins such as cytochrome c (Fig. 2B), inducing intrinsic apoptosis within the cytoplasm when complexed with APAF-1 (55). However, reports also show that this apoptosis pathway can proceed in an APAF-1-independent manner (54), indicating the presence of another Ca2+-dependent apoptosis pathway.

Picornavirus infection results in an increase in cytoplasmic Ca2+ concentrations dependent on viral gene expression (56, 57), probably through 2B protein activity (58) (Fig. 2B). Coxsackievirus B 3 (CVB3) 2B protein consists of two hydrophobic regions and inserts into Golgi complex and ER membranes as an integral membrane pore (Fig. 2B) (58, 59). 2B expression leads to downregulation of Ca2+ flux between intracellular stores and the mitochondria, proposing a mechanism by which the protein could suppress intrinsic, Ca2+-induced apoptosis (Fig. 2B) (56, 59). The Ca2+ released via 2B pores is not taken up by the mitochondria, as would normally occur in release via IP3R and RyR (56). The importance of 2B protein is exemplified by the fact that Picornavirus 2B proteins are highly conserved (58). The CV, PV, and human rhinovirus (HRV) 2B proteins all contain similar, functionally important, conserved hydrophobic domains (58). Paralleling this, subcellular localization studies showed that PV and HRV14 2B localize to the Golgi complex and disrupt the ER Ca2+ stores (58). The disruption of subcellular Ca2+ concentrations could be a mechanism by which picornaviruses are able to suppress the intrinsic apoptotic response, by subverting Ca2+ signaling to the mitochondria.

dsRNA sensors.RIG-I and MDA-5 are implicated in host responses to Picornavirus infection (27). The activation of RIG-I in Picornaviridae infection has been debated with Wang et al. (99) indicating that RIG-I is not activated upon HRV infection, but Slater et al. (27) showing that RIG-I and MDA-5 activation occurs later in infection, coordinating with TLR-3 activation. The mechanism by which endosomally located TLR-3 recognizes cytoplasmic HRV dsRNA is unknown; however, it has been proposed that RNA secondary structures formed by the single strand within the endosome may be recognized by TLR-3 (27).

The importance of picornaviruses attenuating this pathway is highlighted by the multiple components that are cleaved by viral proteases (Fig. 2C and 3A and Table 1). The RNA sensors are cleaved by multiple picornaviruses. Barral et al. (60) have shown that RIG-I is cleaved during PV, major and minor group HRV, encephalomyocarditis virus (EMCV), and echovirus infection (61). Furthermore, exogenous addition via transfection or in vitro addition of the PV 3C protease leads to degradation of RIG-I similar to that seen in infection, indicating that it is the most likely cause of cleavage in Picornavirus infection (60). Multiple viruses have been shown to cleave IPS-1, thus disrupting virus-induced downstream signaling. Notably, HRV1a, PV, coxsackievirus (8, 62), and hepatitis A virus (HAV) (63) proteases have been shown to cleave IPS-1, all disrupting downstream functions (Fig. 2C). Hepatitis C virus (HCV) (a flavivirus), protease NS3/4A has been shown to cleave IPS-1 near the N-terminal transmembrane domain (64) which disrupts mitochondrial localization of IPS-1 (64), essential for downstream signaling (65, 66). While limited data are available, IPS-1 is cleaved in HAV infection in a similar manner and releases IPS-1 from the mitochondria (63), possibly disrupting intrinsic apoptosis.

View this table:
  • View inline
  • View popup
TABLE 1 

Proapoptotic factors cleaved in picornavirus infection

Cleavage of IPS-1, releasing the death receptor complex from its mitochondrial anchor would also be expected to result in inhibition of extrinsic apoptosis (Fig. 3A). In addition, picornaviruses target the helicase activation-dependent proinflammatory pathways. Ubiquination of RIPK1 at lysine 377 acts as a scaffold which is recognized by the IKKγ (Nemo) subunit of the IKKα-IKKβ-IKKγ complex (Fig. 3A), activating the latter which allows the subsequent phosphorylation and degradation of iKB (31), releasing NF-κB which translocates into the nucleus to upregulate the expression of proinflammatory genes. Foot-and-mouth disease virus (FMDV) 3C protease cleaves IKKγ, effectively disrupting the activation of NF-κB (Fig. 3A).

FIG 3 
  • Open in new tab
  • Download powerpoint
FIG 3 

Effects of picornavirus infections on extrinsic apoptosis pathways. (A) Sensing of dsRNA by RIG-I/MDA-5 leads to the formation of a death receptor complex at the mitochondria through the adaptor protein IPS-1. Subsequent ubiquination of RIPK1 is recognized by the IKKγ (Nemo) subunit of the IKKα-IKKβ-IKKγ complex, leading to phosphorylation and degradation of IκB and release of NF-κB that translocates into the nucleus to upregulate expression of proapoptotic genes. Cleavage of RIG-I and IPS-1 by various picornaviruses (indicated in red) disrupts extrinsic apoptosis signaling. Foot-and-mouth disease virus (FMDV) infection results in cleavage of IKKγ, abrogating NF-kB activation and attenuating transcriptional activation of proapoptotic factors. (B) Sensing of dsRNA by TLR3 and subsequent recruitment of TRIF initiates the formation of a death receptor complex, leading to induction of extrinsic apoptosis as described in the legend to Fig. 1. TRIF is cleaved in infection by multiple picornaviruses (indicated in red) resulting in disruption of the death receptor complex and inhibition of extrinsic apoptosis. P, phosphate; DD, death domain; RHIM, RIP homotypic interaction motif.

TLR pathways.TRIF is cleaved at two sites within its N-terminal and C-terminal regions in cells infected with CVB3 (8) (Fig. 3B). Ectopic expression of the CVB3 3C protease confirmed it as the enzyme responsible for cleavage (8). The same report also noted that the virus-induced truncated form of TRIF was unable to mount IFN or apoptotic responses, likely due to the cleavage at the C-terminal region of TRIF (8). The picornaviral cleavage of TRIF has also been shown in EV71 (67), EV68 (68), and HAV (69) infection, suggesting that it may be common to Picornaviridae. Additionally, it was confirmed by multiple sources to be the result of 3C protease (8, 67, 68) or its precursor 3CD protease (69) activity. Whether the viral alteration of TRIF, downregulation of IFN responses reported in EV71 and EV68 infection (67, 68), and impaired IRF-3 responses in HAV infection (69) lead to disruption of apoptosis was not tested. The cleavage of TRIF by HAV occurs at position 554 (69), which is within the proapoptotic C-terminal domain of TRIF (29); thus, the cleavage of adaptor proteins within this pathway may be a mechanism of modulating the host apoptotic response.

Nuclear cytoplasmic trafficking and apoptosis.The genomic content in eukaryotes is separated from the rest of the cell by the double lipid bilayer of the nuclear envelope (NE). The NE is interrupted by pores, the only avenue for bidirectional transport of molecules across the NE (70). The nuclear pore complex (NPC), is comprised of approximately 500 to 1,000 nucleoporins (Nups), of which there are approximately 30 types (reviewed in references 70 and 71). NPCs contain a hollow central core, a nuclear basket, a lumenal ring, and cytoplasmic filaments. Nups lining the central core have numerous phenylalanine and glycine repeats (FG Nups) and mediate nucleocytoplasmic transport via interaction with nuclear transporters termed importins (IMPs) or exportins (EXPs) (71). The nuclear import cycle is mediated by direct binding of IMPβ to cargo molecules through their nuclear localization signals (NLSs) or indirect binding via an adaptor protein (IMPα). Cytoplasmic filaments provide the initial docking site for the import complex which moves through the NPC facilitated by the FG Nups. In the nucleus, RanGTP binds to the IMPβ complex which induces cargo displacement, and IMPβ-RanGTP is transported back into the cytoplasm. Nuclear export is similar to nuclear import in the opposite direction. The best-characterized EXP is CRM1 that recognizes proteins with a leucine-rich nuclear export signal (NES) and in complex with RanGTP, translocates the complex to the cytoplasm through the NPC. In the cytoplasm, RanGTP is hydrolyzed to cause dissociation of the CRM1-RanGTP-cargo complex. The unbound CRM1 and RanGDP are free to recycle back into the nucleus to repeat the cycle.

Procaspase-3 is located in cytoplasmic fractions of nonapoptotic cells and the nuclear fraction of apoptotic cells (72), indicating its nuclear translocation in response to apoptotic stimuli, correlating with the nuclear location of caspase 3 substrates (73). Caspase 3 harbors a NES that keeps it in the cytoplasm in its procaspase form. Activation of caspase 3 followed by a specific substrate recognition leads to masking/abrogation of the NES activity, resulting in nuclear localization of caspase 3 (73–75).

Protein kinase Cδ (PKCδ) is a proapoptotic protein that accumulates in the nucleus during apoptosis. Full-length PKCδ is found in all cells, whereas the catalytic fragment of PKCδ, generated by caspase cleavage, is present only in cells undergoing apoptosis. PKCδ normally shuttles between the nucleus and the cytoplasm. In cells undergoing apoptosis, it is cleaved by caspase 3 in the nucleus, disrupting its NES and resulting in nuclear accumulation (76, 77).

Disruption of nucleocytoplasmic trafficking.Many picornaviruses cleave or alter proteins involved in nucleocytoplasmic transport (as reviewed in reference 78), thereby disrupting host processes and promoting viral replication. The extent that viral modulation of NPCs causes disruption of apoptosis pathways has not been investigated extensively; however, the orchestrated nucleocytoplasmic transport of pro- and antiapoptotic factors has been studied and reviewed (79–81).

Cells infected with PV have mislocalization of select endogenous NLS-containing proteins and a green fluorescent protein (GFP)-tagged reporter protein containing an NLS to the cytoplasm due to the inability of import complexes to dock to the NPC (82). Coinciding with the decrease in nucleocytoplasmic transport, key FG Nups (71, 83, 84), Nup153, and Nup62 were degraded in PV infection in a manner dissimilar to that seen in apoptosis (82). Studies have since shown cleavage of Nup153, -98, and -62 in HRV infection (3, 4), with HRV 2A protease likely responsible for Nup62 and Nup98 cleavage (85, 86) and HRV 3C protease likely responsible for Nup153 cleavage (3). Additionally, HRV 3C protease increased the permeability of the NE to large molecules (>100 kDa) in a perforated cell system (87). Together, these results indicate that cytoplasmic accumulation of nuclear or NLS-containing proteins and nuclear accumulation of molecules that cannot normally access the nucleus are, at least partially, due to the cleavage of Nups by picornaviral proteases.

Notably, an increase in nuclear permeability is also seen in infection with cardioviruses, specifically encephalomyocarditis virus (EMCV) (88) and Theiler’s murine encephalomyelitis virus (TMEV) (89). Cardioviruses lack a protein homologous to the enterovirus (e.g., PV and HRV) 2A protease, and instead the NE alterations are dependent on the viral leader (L) protein (88, 89). Albeit by different mechanisms, the increased permeability of the NPC appears to be conserved among several Picornavirus genera, implying that this change is an important modification in Picornavirus infection.

While the mislocalization of specific proapoptotic proteins as a result of alterations to the NPC by picornaviruses is not fully understood, the orchestrated manner by which these proteins move into the nucleus may be affected by virus-induced changes.

Picornavirus-induced relocalization of Sam68.Early reports drew a link between apoptosis and Sam68 (Src-associated substrate in mitosis of 68 kDa), as knockout of Sam68 led to transformation of fibroblasts into a neoplastic phenotype (90). Later research confirmed the role of Sam68 in apoptosis, with overexpression of Sam68 arresting cell cycle progression and inducing apoptosis (91). Sam68 also acts as an adaptor protein for the formation of tumor necrosis factor alpha (TNF-α)- and TLR-3-induced death receptor complexes (Fig. 4A and B) (92, 93). Recruitment of receptor-interacting protein kinase 1 (RIPK1) to the apoptosis-inducing receptor complex appears to be dependent on Sam68. Although caspase 8 is able to bind FADD (Fas-associated adaptor protein with death domain) in the absence of Sam68, the complex is biologically inactive (93).

FIG 4 
  • Open in new tab
  • Download powerpoint
FIG 4 

Effects of picornavirus infections on nuclear pore and Sam68. (A) Sam68 (yellow and green) shuttles between the cytoplasm and nucleus, being located predominately in the nucleus in healthy cells, with cytoplasmic cell death proteins in precursor, inactive form. (B) With the detection of dsRNA by RIG-I/MDA-5 or TLR-3, procaspase-8 is recruited to the complex formed, inducing activation of caspase 8 and recruitment of death receptor proteins, e.g., FADD and RIPK1. Death receptor complex signaling is dependent on recruitment of cytoplasmic Sam68. (C) Disruption of the NPC in picornavirus infection (i) (indicated by broken outline of NPCs) allows passive movement of Sam68 between the nucleus and the cytoplasm (as indicated by the red double-headed arrow). The NLS motif of Sam68 (green) is cleaved in picornavirus infection (ii), resulting in reduced recruitment of RIPK1 to the FADD complex, rendering it inactive. Loss of the NLS motif also inhibits the active import of Sam68 into the nucleus (ii), retaining it in the cytoplasm. Last, the viral genomic element, IRES, binds Sam68 within the cytoplasm (iii), allowing viral replication.

Sam68 is mislocalized in Picornavirus infection (Fig. 4C), specifically in enterovirus 71 (EV71) (6, 94), HRV serotypes 2, 16 (5), and 14 (4), foot-and-mouth-disease virus (FMDV) (95), and PV (96) infection. Initially, disruption of the nuclear accumulation of Sam68 by picornaviruses was attributed to the disruption of the NPC by the viral proteases [Fig. 4C(i)] (4); however, recent research shows that the cytoplasmic redistribution of Sam68 precedes nucleoporin cleavage (95). The latter study also confirmed direct cleavage of Sam68 by FMDV 3C protease [Fig. 4C(ii)], which disrupts the NLS within the Sam68 C-terminal domain (95). The observed mislocalization of Sam68 in picornavirus-infected cells is probably due both to the disruption of NPC and the loss of its NLS; the former may allow Sam68 to diffuse across the NE in both directions, while loss of the NLS would retain it in the cytoplasm. It is also important to note that Sam68 is involved in viral replication within the cytoplasm; during infection, Sam68 interacts with viral elements, the internal ribosome entry site (IRES) [Fig. 4C(iii)] and the viral RNA-dependent RNA polymerase 3Dpol (95–97), and cytoplasmic virus-induced stress granules (97, 98), and sequestration of cytoplasmic Sam68 by viral structures may interfere with recruitment to death signaling complexes.

CONCLUSION

The Picornavirus proteases are not only essential for cleavage of viral polyprotein but they also target cellular factors to shut down cellular processes disruptive to the virus. Ultimately, the viral control of cell death pathways, in particular apoptosis, is essential for optimal replication of picornaviruses. It is both the timely inhibition and then the induction of apoptosis that are thought to allow optimal viral replication, and it is evident that the suppression of proapoptotic factors, as discussed in this minireview, is a viral strategy to shut down innate immune responses. Overall, understanding of the actions of the viral proteases contributes to the understanding of establishment of infection and subsequent pathogenesis, an essential first step toward viable therapeutic strategies.

  • Copyright © 2017 Croft et al.

This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license .

REFERENCES

  1. 1.↵
    1. Deszcz L,
    2. Seipelt J,
    3. Vassilieva E,
    4. Roetzer A,
    5. Kuechler E
    . 2004. Antiviral activity of caspase inhibitors: effect on picornaviral 2A proteinase. FEBS Lett560:51–55. doi:10.1016/S0014-5793(04)00069-9.
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    1. Belov GA,
    2. Romanova LI,
    3. Tolskaya EA,
    4. Kolesnikova MS,
    5. Lazebnik YA,
    6. Agol VI
    . 2003. The major apoptotic pathway activated and suppressed by poliovirus. J Virol77:45–56. doi:10.1128/JVI.77.1.45-56.2003.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Walker EJ,
    2. Younessi P,
    3. Fulcher AJ,
    4. McCuaig R,
    5. Thomas BJ,
    6. Bardin PG,
    7. Jans DA,
    8. Ghildyal R
    . 2013. Rhinovirus 3C protease facilitates specific nucleoporin cleavage and mislocalisation of nuclear proteins in infected host cells. PLoS One8:e71316. doi:10.1371/journal.pone.0071316.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Gustin KE,
    2. Sarnow P
    . 2002. Inhibition of nuclear import and alteration of nuclear pore complex composition by rhinovirus. J Virol76:8787–8796. doi:10.1128/JVI.76.17.8787-8796.2002.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Walker EJ,
    2. Jensen LM,
    3. Croft S,
    4. Ghildyal R
    . 2015. Variation in the nuclear effects of infection by different human rhinovirus serotypes. Front Microbiol6:875. doi:10.3389/fmicb.2015.00875.
    OpenUrlCrossRef
  6. 6.↵
    1. Zhang H,
    2. Cong H,
    3. Song L,
    4. Tien P
    . 2014. The nuclear protein Sam68 is redistributed to the cytoplasm and is involved in PI3K/Akt activation during EV71 infection. Virus Res180:1–11. doi:10.1016/j.virusres.2013.11.020.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Wang D,
    2. Fang L,
    3. Li K,
    4. Zhong H,
    5. Fan J,
    6. Ouyang C,
    7. Zhang H,
    8. Duan E,
    9. Luo R,
    10. Zhang Z,
    11. Liu X,
    12. Chen H,
    13. Xiao S
    . 2012. Foot-and-mouth disease virus 3C protease cleaves NEMO to impair innate immune signaling. J Virol86:9311–9322. doi:10.1128/JVI.00722-12.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Mukherjee A,
    2. Morosky SA,
    3. Delorme-Axford E,
    4. Dybdahl-Sissoko N,
    5. Oberste MS,
    6. Wang T,
    7. Coyne CB
    . 2011. The coxsackievirus B-3C protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling. PLoS Pathog7:e1001311. doi:10.1371/journal.ppat.1001311.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Palmenberg AC,
    2. Spiro D,
    3. Kuzmickas R,
    4. Wang S,
    5. Djikeng A,
    6. Rathe JA,
    7. Fraser-Liggett CM,
    8. Liggett SB
    . 2009. Sequencing and analyses of all known human rhinovirus genomes reveal structure and evolution. Science324:55–59. doi:10.1126/science.1165557.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Hull HF,
    2. Ward NA,
    3. Hull BP,
    4. Milstien JB,
    5. de Quadros C
    . 1994. Paralytic poliomyelitis: seasoned strategies, disappearing disease. Lancet343:1331–1337. doi:10.1016/S0140-6736(94)92472-4.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. Lewis-Rogers N,
    2. Crandall KA
    . 2010. Evolution of Picornaviridae: an examination of phylogenetic relationships and cophylogeny. Mol Phylogenet Evol54:995–1005. doi:10.1016/j.ympev.2009.10.015.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Palmenberg AC,
    2. Gern JE
    . 2015. Classification and evolution of human rhinoviruses. Methods Mol Biol1221:1–10. doi:10.1007/978-1-4939-1571-2_1.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Racaniello VR
    . 2001. Picornaviridae: the viruses and their replication, p 685–722. InKnipe DM, Howley PM (ed), Fields virology, 4th ed. Lippincott/Raven, Philadelphia, PA.
  14. 14.↵
    1. Cordey S,
    2. Gerlach D,
    3. Junier T,
    4. Zdobnov EM,
    5. Kaiser L,
    6. Tapparel C
    . 2008. The cis-acting replication elements define human enterovirus and rhinovirus species. RNA14:1568–1578. doi:10.1261/rna.1031408.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Tidball JG,
    2. Albrecht DE,
    3. Lokensgard BE,
    4. Spencer MJ
    . 1995. Apoptosis precedes necrosis of dystrophin-deficient muscle. J Cell Sci108:2197–2204.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Ankarcrona M,
    2. Dypbukt JM,
    3. Bonfoco E,
    4. Zhivotovsky B,
    5. Orrenius S,
    6. Lipton SA,
    7. Nicotera P
    . 1995. Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron15:961–973. doi:10.1016/0896-6273(95)90186-8.
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    1. Gavrieli Y,
    2. Sherman Y,
    3. Ben-Sasson SA
    . 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol119:493–501. doi:10.1083/jcb.119.3.493.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. Sakahira H,
    2. Enari M,
    3. Nagata S
    . 1998. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature391:96–99. doi:10.1038/34214.
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.↵
    1. Galluzzi L,
    2. Brenner C,
    3. Morselli E,
    4. Touat Z,
    5. Kroemer G
    . 2008. Viral control of mitochondrial apoptosis. PLoS Pathog4:e1000018. doi:10.1371/journal.ppat.1000018.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Oleszak EL,
    2. Hoffman BE,
    3. Chang JR,
    4. Zaczynska E,
    5. Gaughan J,
    6. Katsetos CD,
    7. Platsoucas CD,
    8. Harvey N
    . 2003. Apoptosis of infiltrating T cells in the central nervous system of mice infected with Theiler’s murine encephalomyelitis virus. Virology315:110–123. doi:10.1016/S0042-6822(03)00517-8.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Tolskaya EA,
    2. Romanova LI,
    3. Kolesnikova MS,
    4. Ivannikova TA,
    5. Smirnova EA,
    6. Raikhlin NT,
    7. Agol VI
    . 1995. Apoptosis-inducing and apoptosis-preventing functions of poliovirus. J Virol69:1181–1189.
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    1. Vercammen D,
    2. Brouckaert G,
    3. Denecker G,
    4. Van de Craen M,
    5. Declercq W,
    6. Fiers W,
    7. Vandenabeele P
    . 1998. Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways. J Exp Med188:919–930. doi:10.1084/jem.188.5.919.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Oshiumi H,
    2. Matsumoto M,
    3. Funami K,
    4. Akazawa T,
    5. Seya T
    . 2003. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. Nat Immunol4:161–167. doi:10.1038/ni886.
    OpenUrlCrossRefPubMedWeb of Science
  24. 24.↵
    1. Stennicke HR,
    2. Jürgensmeier JM,
    3. Shin H,
    4. Deveraux Q,
    5. Wolf BB,
    6. Yang X,
    7. Zhou Q,
    8. Ellerby HM,
    9. Ellerby LM,
    10. Bredesen D,
    11. Green DR,
    12. Reed JC,
    13. Froelich CJ,
    14. Salvesen GS
    . 1998. Pro-caspase-3 is a major physiologic target of caspase-8. J Biol Chem273:27084–27090. doi:10.1074/jbc.273.42.27084.
    OpenUrlAbstract/FREE Full Text
  25. 25.↵
    1. Slee EA,
    2. Adrain C,
    3. Martin SJ
    . 2001. Executioner caspase-3, -6, and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis. J Biol Chem276:7320–7326. doi:10.1074/jbc.M008363200.
    OpenUrlAbstract/FREE Full Text
  26. 26.↵
    1. Adam-Klages S,
    2. Schwandner R,
    3. Lüschen S,
    4. Ussat S,
    5. Kreder D,
    6. Krönke M
    . 1998. Caspase-mediated inhibition of human cytosolic phospholipase A2 during apoptosis. J Immunol161:5687–5694.
    OpenUrlAbstract/FREE Full Text
  27. 27.↵
    1. Slater L,
    2. Bartlett NW,
    3. Haas JJ,
    4. Zhu J,
    5. Message SD,
    6. Walton RP,
    7. Sykes A,
    8. Dahdaleh S,
    9. Clarke DL,
    10. Belvisi MG,
    11. Kon OM,
    12. Fujita T,
    13. Jeffery PK,
    14. Johnston SL,
    15. Edwards MR
    . 2010. Co-ordinated role of TLR3, RIG-I and MDA5 in the innate response to rhinovirus in bronchial epithelium. PLoS Pathog6:e1001178. doi:10.1371/journal.ppat.1001178.
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. Estornes Y,
    2. Toscano F,
    3. Virard F,
    4. Jacquemin G,
    5. Pierrot A,
    6. Vanbervliet B,
    7. Bonnin M,
    8. Lalaoui N,
    9. Mercier-Gouy P,
    10. Pachéco Y,
    11. Salaun B,
    12. Renno T,
    13. Micheau O,
    14. Lebecque S
    . 2012. dsRNA induces apoptosis through an atypical death complex associating TLR3 to caspase-8. Cell Death Differ19:1482–1494. doi:10.1038/cdd.2012.22.
    OpenUrlCrossRefPubMed
  29. 29.↵
    1. Han K-J,
    2. Su X,
    3. Xu L-G,
    4. Bin L-H,
    5. Zhang J,
    6. Shu H-B
    . 2004. Mechanisms of the TRIF-induced interferon-stimulated response element and NF-κB activation and apoptosis pathways. J Biol Chem279:15652–15661. doi:10.1074/jbc.M311629200.
    OpenUrlAbstract/FREE Full Text
  30. 30.↵
    1. Kaiser WJ,
    2. Offermann MK
    . 2005. Apoptosis induced by the Toll-like receptor adaptor TRIF is dependent on its receptor interacting protein homotypic interaction motif. J Immunol174:4942–4952. doi:10.4049/jimmunol.174.8.4942.
    OpenUrlAbstract/FREE Full Text
  31. 31.↵
    1. Kumar H,
    2. Kawai T,
    3. Kato H,
    4. Sato S,
    5. Takahashi K,
    6. Coban C,
    7. Yamamoto M,
    8. Uematsu S,
    9. Ishii KJ,
    10. Takeuchi O,
    11. Akira S
    . 2006. Essential role of IPS-1 in innate immune responses against RNA viruses. J Exp Med203:1795–1803. doi:10.1084/jem.20060792.
    OpenUrlAbstract/FREE Full Text
  32. 32.↵
    1. Chattopadhyay S,
    2. Sen GC
    . 2014. dsRNA-activation of TLR3 and RLR signaling: gene induction-dependent and independent effects. J Interferon Cytokine Res34:427–436. doi:10.1089/jir.2014.0034.
    OpenUrlCrossRefPubMed
  33. 33.↵
    1. Besch R,
    2. Poeck H,
    3. Hohenauer T,
    4. Senft D,
    5. Häcker G,
    6. Berking C,
    7. Hornung V,
    8. Endres S,
    9. Ruzicka T,
    10. Rothenfusser S,
    11. Hartmann G
    . 2009. Proapoptotic signaling induced by RIG-I and MDA-5 results in type I interferon-independent apoptosis in human melanoma cells. J Clin Invest119:2399–2411. doi:10.1172/JCI37155.
    OpenUrlCrossRefPubMedWeb of Science
  34. 34.↵
    1. Chattopadhyay S,
    2. Marques JT,
    3. Yamashita M,
    4. Peters KL,
    5. Smith K,
    6. Desai A,
    7. Williams BR,
    8. Sen GC
    . 2010. Viral apoptosis is induced by IRF-3-mediated activation of Bax. EMBO J29:1762–1773. doi:10.1038/emboj.2010.50.
    OpenUrlAbstract/FREE Full Text
  35. 35.↵
    1. Okazaki T,
    2. Higuchi M,
    3. Gotoh Y
    . 2013. Mitochondrial localization of the antiviral signaling adaptor IPS-1 is important for its induction of caspase activation. Genes Cells18:493–501. doi:10.1111/gtc.12052.
    OpenUrlCrossRefPubMed
  36. 36.↵
    1. Rajput A,
    2. Kovalenko A,
    3. Bogdanov K,
    4. Yang SH,
    5. Kang TB,
    6. Kim JC,
    7. Du J,
    8. Wallach D
    . 2011. RIG-I RNA helicase activation of IRF3 transcription factor is negatively regulated by caspase-8-mediated cleavage of the RIP1 protein. Immunity34:340–351. doi:10.1016/j.immuni.2010.12.018.
    OpenUrlCrossRefPubMedWeb of Science
  37. 37.↵
    1. Holm GH,
    2. Zurney J,
    3. Tumilasci V,
    4. Leveille S,
    5. Danthi P,
    6. Hiscott J,
    7. Sherry B,
    8. Dermody TS
    . 2007. Retinoic acid-inducible gene-I and interferon-beta promoter stimulator-1 augment proapoptotic responses following mammalian reovirus infection via interferon regulatory factor-3. J Biol Chem282:21953–21961. doi:10.1074/jbc.M702112200.
    OpenUrlAbstract/FREE Full Text
  38. 38.↵
    1. El Maadidi S,
    2. Faletti L,
    3. Berg B,
    4. Wenzl C,
    5. Wieland K,
    6. Chen ZJ,
    7. Maurer U,
    8. Borner C
    . 2014. A novel mitochondrial MAVS/caspase-8 platform links RNA virus-induced innate antiviral signaling to Bax/Bak-independent apoptosis. J Immunol192:1171–1183. doi:10.4049/jimmunol.1300842.
    OpenUrlAbstract/FREE Full Text
  39. 39.↵
    1. Li HM,
    2. Fujikura D,
    3. Harada T,
    4. Uehara J,
    5. Kawai T,
    6. Akira S,
    7. Reed JC,
    8. Iwai A,
    9. Miyazaki T
    . 2009. IPS-1 is crucial for DAP3-mediated anoikis induction by caspase-8 activation. Cell Death Differ16:1615–1621. doi:10.1038/cdd.2009.97.
    OpenUrlCrossRefPubMed
  40. 40.↵
    1. Miyazaki T,
    2. Reed JC
    . 2001. A GTP-binding adapter protein couples TRAIL receptors to apoptosis-inducing proteins. Nat Immunol2:493–500. doi:10.1038/88684.
    OpenUrlCrossRefPubMedWeb of Science
  41. 41.↵
    1. Lemaire PA,
    2. Anderson E,
    3. Lary J,
    4. Cole JL
    . 2008. Mechanism of PKR activation by dsRNA. J Mol Biol381:351–360. doi:10.1016/j.jmb.2008.05.056.
    OpenUrlCrossRefPubMedWeb of Science
  42. 42.↵
    1. Saelens X,
    2. Kalai M,
    3. Vandenabeele P
    . 2001. Translation inhibition in apoptosis: caspase-dependent PKR activation and eIF2-α phosphorylation. J Biol Chem276:41620–41628. doi:10.1074/jbc.M103674200.
    OpenUrlAbstract/FREE Full Text
  43. 43.↵
    1. Gil J,
    2. Alcamí J,
    3. Esteban M
    . 1999. Induction of apoptosis by double-stranded-RNA-dependent protein kinase (PKR) involves the α subunit of eukaryotic translation initiation factor 2 and NF-κB. Mol Cell Biol19:4653–4663. doi:10.1128/MCB.19.7.4653.
    OpenUrlAbstract/FREE Full Text
  44. 44.↵
    1. Srivastava SP,
    2. Kumar KU,
    3. Kaufman RJ
    . 1998. Phosphorylation of eukaryotic translation initiation factor 2 mediates apoptosis in response to activation of the double-stranded RNA-dependent protein kinase. J Biol Chem273:2416–2423. doi:10.1074/jbc.273.4.2416.
    OpenUrlAbstract/FREE Full Text
  45. 45.↵
    1. Gil J,
    2. Esteban M
    . 2000. Induction of apoptosis by the dsRNA-dependent protein kinase (PKR): mechanism of action. Apoptosis5:107–114. doi:10.1023/A:1009664109241.
    OpenUrlCrossRefPubMedWeb of Science
  46. 46.↵
    1. Gil J,
    2. Esteban M
    . 2000. The interferon-induced protein kinase (PKR), triggers apoptosis through FADD-mediated activation of caspase 8 in a manner independent of Fas and TNF-alpha receptors. Oncogene19:3665–3674. doi:10.1038/sj.onc.1203710.
    OpenUrlCrossRefPubMedWeb of Science
  47. 47.↵
    1. Zhang P,
    2. Samuel CE
    . 2008. Induction of protein kinase PKR-dependent activation of interferon regulatory factor 3 by vaccinia virus occurs through adapter IPS-1 signaling. J Biol Chem283:34580–34587. doi:10.1074/jbc.M807029200.
    OpenUrlAbstract/FREE Full Text
  48. 48.↵
    1. Tait SW,
    2. Green DR
    . 2010. Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol11:621–632. doi:10.1038/nrm2952.
    OpenUrlCrossRefPubMedWeb of Science
  49. 49.↵
    1. Czabotar PE,
    2. Lessene G,
    3. Strasser A,
    4. Adams JM
    . 2014. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat Rev Mol Cell Biol15:49–63. doi:10.1038/nrm3722.
    OpenUrlCrossRefPubMed
  50. 50.↵
    1. Slee EA,
    2. Harte MT,
    3. Kluck RM,
    4. Wolf BB,
    5. Casiano CA,
    6. Newmeyer DD,
    7. Wang HG,
    8. Reed JC,
    9. Nicholson DW,
    10. Alnemri ES,
    11. Green DR,
    12. Martin SJ
    . 1999. Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J Cell Biol144:281–292. doi:10.1083/jcb.144.2.281.
    OpenUrlAbstract/FREE Full Text
  51. 51.↵
    1. Yoshida H,
    2. Kong YY,
    3. Yoshida R,
    4. Elia AJ,
    5. Hakem A,
    6. Hakem R,
    7. Penninger JM,
    8. Mak TW
    . 1998. Apaf1 is required for mitochondrial pathways of apoptosis and brain development. Cell94:739–750. doi:10.1016/S0092-8674(00)81733-X.
    OpenUrlCrossRefPubMedWeb of Science
  52. 52.↵
    1. Zhang L,
    2. Yu J,
    3. Park BH,
    4. Kinzler KW,
    5. Vogelstein B
    . 2000. Role of BAX in the apoptotic response to anticancer agents. Science290:989–992. doi:10.1126/science.290.5493.989.
    OpenUrlAbstract/FREE Full Text
  53. 53.↵
    1. Wu CC,
    2. Lee S,
    3. Malladi S,
    4. Chen MD,
    5. Mastrandrea NJ,
    6. Zhang Z,
    7. Bratton SB
    . 2016. The Apaf-1 apoptosome induces formation of caspase-9 homo- and heterodimers with distinct activities. Nat Commun7:13565. doi:10.1038/ncomms13565.
    OpenUrlCrossRef
  54. 54.↵
    1. Rao RV,
    2. Castro-Obregon S,
    3. Frankowski H,
    4. Schuler M,
    5. Stoka V,
    6. del Rio G,
    7. Bredesen DE,
    8. Ellerby HM
    . 2002. Coupling endoplasmic reticulum stress to the cell death program. An Apaf-1-independent intrinsic pathway. J Biol Chem277:21836–21842. doi:10.1074/jbc.M202726200.
    OpenUrlAbstract/FREE Full Text
  55. 55.↵
    1. Deniaud A,
    2. Sharaf el dein O,
    3. Maillier E,
    4. Poncet D,
    5. Kroemer G,
    6. Lemaire C,
    7. Brenner C
    . 2008. Endoplasmic reticulum stress induces calcium-dependent permeability transition, mitochondrial outer membrane permeabilization and apoptosis. Oncogene27:285–299. doi:10.1038/sj.onc.1210638.
    OpenUrlCrossRefPubMedWeb of Science
  56. 56.↵
    1. Brisac C,
    2. Téoulé F,
    3. Autret A,
    4. Pelletier I,
    5. Colbère-Garapin F,
    6. Brenner C,
    7. Lemaire C,
    8. Blondel B
    . 2010. Calcium flux between the endoplasmic reticulum and mitochondrion contributes to poliovirus-induced apoptosis. J Virol84:12226–12235. doi:10.1128/JVI.00994-10.
    OpenUrlAbstract/FREE Full Text
  57. 57.↵
    1. Irurzun A,
    2. Arroyo J,
    3. Alvarez A,
    4. Carrasco L
    . 1995. Enhanced intracellular calcium concentration during poliovirus infection. J Virol69:5142–5146.
    OpenUrlAbstract/FREE Full Text
  58. 58.↵
    1. de Jong AS,
    2. de Mattia F,
    3. Van Dommelen MM,
    4. Lanke K,
    5. Melchers WJ,
    6. Willems PH,
    7. van Kuppeveld FJ
    . 2008. Functional analysis of picornavirus 2B proteins: effects on calcium homeostasis and intracellular protein trafficking. J Virol82:3782–3790. doi:10.1128/JVI.02076-07.
    OpenUrlAbstract/FREE Full Text
  59. 59.↵
    1. Campanella M,
    2. de Jong AS,
    3. Lanke KW,
    4. Melchers WJ,
    5. Willems PH,
    6. Pinton P,
    7. Rizzuto R,
    8. van Kuppeveld FJ
    . 2004. The coxsackievirus 2B protein suppresses apoptotic host cell responses by manipulating intracellular Ca2+ homeostasis. J Biol Chem279:18440–18450. doi:10.1074/jbc.M309494200.
    OpenUrlAbstract/FREE Full Text
  60. 60.↵
    1. Barral PM,
    2. Sarkar D,
    3. Fisher PB,
    4. Racaniello VR
    . 2009. RIG-I is cleaved during picornavirus infection. Virology391:171–176. doi:10.1016/j.virol.2009.06.045.
    OpenUrlCrossRefPubMedWeb of Science
  61. 61.↵
    1. Papon L,
    2. Oteiza A,
    3. Imaizumi T,
    4. Kato H,
    5. Brocchi E,
    6. Lawson TG,
    7. Akira S,
    8. Mechti N
    . 2009. The viral RNA recognition sensor RIG-I is degraded during encephalomyocarditis virus (EMCV) infection. Virology393:311–318. doi:10.1016/j.virol.2009.08.009.
    OpenUrlCrossRefPubMedWeb of Science
  62. 62.↵
    1. Drahos J,
    2. Racaniello VR
    . 2009. Cleavage of IPS-1 in cells infected with human rhinovirus. J Virol83:11581–11587. doi:10.1128/JVI.01490-09.
    OpenUrlAbstract/FREE Full Text
  63. 63.↵
    1. Yang Y,
    2. Liang Y,
    3. Qu L,
    4. Chen Z,
    5. Yi M,
    6. Li K,
    7. Lemon SM
    . 2007. Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor. Proc Natl Acad Sci U S A104:7253–7258. doi:10.1073/pnas.0611506104.
    OpenUrlAbstract/FREE Full Text
  64. 64.↵
    1. Lin R,
    2. Lacoste J,
    3. Nakhaei P,
    4. Sun Q,
    5. Yang L,
    6. Paz S,
    7. Wilkinson P,
    8. Julkunen I,
    9. Vitour D,
    10. Meurs E,
    11. Hiscott J
    . 2006. Dissociation of a MAVS/IPS-1/VISA/Cardif-IKKε molecular complex from the mitochondrial outer membrane by hepatitis C virus NS3-4A proteolytic cleavage. J Virol80:6072–6083. doi:10.1128/JVI.02495-05.
    OpenUrlAbstract/FREE Full Text
  65. 65.↵
    1. Seth RB,
    2. Sun L,
    3. Ea C-K,
    4. Chen ZJ
    . 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-κB and IRF3. Cell122:669–682. doi:10.1016/j.cell.2005.08.012.
    OpenUrlCrossRefPubMedWeb of Science
  66. 66.↵
    1. Loo YM,
    2. Owen DM,
    3. Li K,
    4. Erickson AK,
    5. Johnson CL,
    6. Fish PM,
    7. Carney DS,
    8. Wang T,
    9. Ishida H,
    10. Yoneyama M,
    11. Fujita T,
    12. Saito T,
    13. Lee WM,
    14. Hagedorn CH,
    15. Lau DT,
    16. Weinman SA,
    17. Lemon SM,
    18. Gale M Jr..
    2006. Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection. Proc Natl Acad Sci U S A103:6001–6006. doi:10.1073/pnas.0601523103.
    OpenUrlAbstract/FREE Full Text
  67. 67.↵
    1. Lei X,
    2. Sun Z,
    3. Liu X,
    4. Jin Q,
    5. He B,
    6. Wang J
    . 2011. Cleavage of the adaptor protein TRIF by enterovirus 71 3C inhibits antiviral responses mediated by Toll-like receptor 3. J Virol85:8811–8818. doi:10.1128/JVI.00447-11.
    OpenUrlAbstract/FREE Full Text
  68. 68.↵
    1. Xiang Z,
    2. Li L,
    3. Lei X,
    4. Zhou H,
    5. Zhou Z,
    6. He B,
    7. Wang J
    . 2014. Enterovirus 68 3C protease cleaves TRIF to attenuate antiviral responses mediated by Toll-like receptor 3. J Virol88:6650–6659. doi:10.1128/JVI.03138-13.
    OpenUrlAbstract/FREE Full Text
  69. 69.↵
    1. Qu L,
    2. Feng Z,
    3. Yamane D,
    4. Liang Y,
    5. Lanford RE,
    6. Li K,
    7. Lemon SM
    . 2011. Disruption of TLR3 signaling due to cleavage of TRIF by the hepatitis A virus protease-polymerase processing intermediate, 3CD. PLoS Pathog7:e1002169. doi:10.1371/journal.ppat.1002169.
    OpenUrlCrossRefPubMed
  70. 70.↵
    1. Lin DH,
    2. Stuwe T,
    3. Schilbach S,
    4. Rundlet EJ,
    5. Perriches T,
    6. Mobbs G,
    7. Fan Y,
    8. Thierbach K,
    9. Huber FM,
    10. Collins LN,
    11. Davenport AM,
    12. Jeon YE,
    13. Hoelz A
    . 2016. Architecture of the symmetric core of the nuclear pore. Science352:aaf1015. doi:10.1126/science.aaf1015.
    OpenUrlAbstract/FREE Full Text
  71. 71.↵
    1. Hoelz A,
    2. Debler EW,
    3. Blobel G
    . 2011. The structure of the nuclear pore complex. Annu Rev Biochem80:613–643. doi:10.1146/annurev-biochem-060109-151030.
    OpenUrlCrossRefPubMedWeb of Science
  72. 72.↵
    1. Zhivotovsky B,
    2. Samali A,
    3. Gahm A,
    4. Orrenius S
    . 1999. Caspases: their intracellular localization and translocation during apoptosis. Cell Death Differ6:644–651. doi:10.1038/sj.cdd.4400536.
    OpenUrlCrossRefPubMedWeb of Science
  73. 73.↵
    1. Ramuz O,
    2. Isnardon D,
    3. Devilard E,
    4. Charafe-Jauffret E,
    5. Hassoun J,
    6. Birg F,
    7. Xerri L
    . 2003. Constitutive nuclear localization and initial cytoplasmic apoptotic activation of endogenous caspase-3 evidenced by confocal microscopy. Int J Exp Pathol84:75–81. doi:10.1046/j.1365-2613.2003.00339.x.
    OpenUrlCrossRefPubMedWeb of Science
  74. 74.↵
    1. Luo M,
    2. Lu Z,
    3. Sun H,
    4. Yuan K,
    5. Zhang Q,
    6. Meng S,
    7. Wang F,
    8. Guo H,
    9. Ju X,
    10. Liu Y,
    11. Ye T,
    12. Lu Z,
    13. Zhai Z
    . 2010. Nuclear entry of active caspase-3 is facilitated by its p3-recognition-based specific cleavage activity. Cell Res20:211–222. doi:10.1038/cr.2010.9.
    OpenUrlCrossRefPubMedWeb of Science
  75. 75.↵
    1. Kamada S,
    2. Kikkawa U,
    3. Tsujimoto Y,
    4. Hunter T
    . 2005. Nuclear translocation of caspase-3 is dependent on its proteolytic activation and recognition of a substrate-like protein(s). J Biol Chem280:857–860. doi:10.1074/jbc.C400538200.
    OpenUrlAbstract/FREE Full Text
  76. 76.↵
    1. DeVries TA,
    2. Neville MC,
    3. Reyland ME
    . 2002. Nuclear import of PKCdelta is required for apoptosis: identification of a novel nuclear import sequence. EMBO J21:6050–6060. doi:10.1093/emboj/cdf606.
    OpenUrlAbstract
  77. 77.↵
    1. DeVries-Seimon TA,
    2. Ohm AM,
    3. Humphries MJ,
    4. Reyland ME
    . 2007. Induction of apoptosis is driven by nuclear retention of protein kinase C δ. J Biol Chem282:22307–22314. doi:10.1074/jbc.M703661200.
    OpenUrlAbstract/FREE Full Text
  78. 78.↵
    1. Flather D,
    2. Semler BL
    . 2015. Picornaviruses and nuclear functions: targeting a cellular compartment distinct from the replication site of a positive-strand RNA virus. Front Microbiol6:594. doi:10.3389/fmicb.2015.00594.
    OpenUrlCrossRefPubMed
  79. 79.↵
    1. Fahrenkrog B
    . 2006. The nuclear pore complex, nuclear transport, and apoptosis. Can J Physiol Pharmacol84:279–286. doi:10.1139/y05-100.
    OpenUrlCrossRefPubMedWeb of Science
  80. 80.↵
    1. Ferrando-May E
    . 2005. Nucleocytoplasmic transport in apoptosis. Cell Death Differ12:1263–1276. doi:10.1038/sj.cdd.4401626.
    OpenUrlCrossRefPubMedWeb of Science
  81. 81.↵
    1. Yasuhara N,
    2. Eguchi Y,
    3. Tachibana T,
    4. Imamoto N,
    5. Yoneda Y,
    6. Tsujimoto Y
    . 1997. Essential role of active nuclear transport in apoptosis. Genes Cells2:55–64. doi:10.1046/j.1365-2443.1997.1010302.x.
    OpenUrlCrossRefPubMedWeb of Science
  82. 82.↵
    1. Gustin KE,
    2. Sarnow P
    . 2001. Effects of poliovirus infection on nucleo-cytoplasmic trafficking and nuclear pore complex composition. EMBO J20:240–249. doi:10.1093/emboj/20.1.240.
    OpenUrlAbstract/FREE Full Text
  83. 83.↵
    1. Cronshaw JM,
    2. Krutchinsky AN,
    3. Zhang W,
    4. Chait BT,
    5. Matunis MJ
    . 2002. Proteomic analysis of the mammalian nuclear pore complex. J Cell Biol158:915–927. doi:10.1083/jcb.200206106.
    OpenUrlAbstract/FREE Full Text
  84. 84.↵
    1. Walther TC,
    2. Fornerod M,
    3. Pickersgill H,
    4. Goldberg M,
    5. Allen TD,
    6. Mattaj IW
    . 2001. The nucleoporin Nup153 is required for nuclear pore basket formation, nuclear pore complex anchoring and import of a subset of nuclear proteins. EMBO J20:5703–5714. doi:10.1093/emboj/20.20.5703.
    OpenUrlAbstract/FREE Full Text
  85. 85.↵
    1. Park N,
    2. Skern T,
    3. Gustin KE
    . 2010. Specific cleavage of the nuclear pore complex protein Nup62 by a viral protease. J Biol Chem285:28796–28805. doi:10.1074/jbc.M110.143404.
    OpenUrlAbstract/FREE Full Text
  86. 86.↵
    1. Fitzgerald KD,
    2. Chase AJ,
    3. Cathcart AL,
    4. Tran GP,
    5. Semler BL
    . 2013. Viral proteinase requirements for the nucleocytoplasmic relocalization of cellular splicing factor SRp20 during picornavirus infections. J Virol87:2390–2400. doi:10.1128/JVI.02396-12.
    OpenUrlAbstract/FREE Full Text
  87. 87.↵
    1. Ghildyal R,
    2. Jordan B,
    3. Li D,
    4. Dagher H,
    5. Bardin PG,
    6. Gern JE,
    7. Jans DA
    . 2009. Rhinovirus 3C protease can localize in the nucleus and alter active and passive nucleocytoplasmic transport. J Virol83:7349–7352. doi:10.1128/JVI.01748-08.
    OpenUrlAbstract/FREE Full Text
  88. 88.↵
    1. Lidsky PV,
    2. Hato S,
    3. Bardina MV,
    4. Aminev AG,
    5. Palmenberg AC,
    6. Sheval EV,
    7. Polyakov VY,
    8. van Kuppeveld FJM,
    9. Agol VI
    . 2006. Nucleocytoplasmic traffic disorder induced by cardioviruses. J Virol80:2705–2717. doi:10.1128/JVI.80.6.2705-2717.2006.
    OpenUrlAbstract/FREE Full Text
  89. 89.↵
    1. Delhaye S,
    2. van Pesch V,
    3. Michiels T
    . 2004. The leader protein of Theiler’s virus interferes with nucleocytoplasmic trafficking of cellular proteins. J Virol78:4357–4362. doi:10.1128/JVI.78.8.4357-4362.2004.
    OpenUrlAbstract/FREE Full Text
  90. 90.↵
    1. Liu K,
    2. Li L,
    3. Nisson PE,
    4. Gruber C,
    5. Jessee J,
    6. Cohen SN
    . 2000. Neoplastic transformation and tumorigenesis associated with sam68 protein deficiency in cultured murine fibroblasts. J Biol Chem275:40195–40201. doi:10.1074/jbc.M006194200.
    OpenUrlAbstract/FREE Full Text
  91. 91.↵
    1. Taylor SJ,
    2. Resnick RJ,
    3. Shalloway D
    . 2004. Sam68 exerts separable effects on cell cycle progression and apoptosis. BMC Cell Biol5:5. doi:10.1186/1471-2121-5-5.
    OpenUrlCrossRefPubMed
  92. 92.↵
    1. Tomalka JA,
    2. de Jesus TJ,
    3. Ramakrishnan P
    . 2017. Sam68 is a regulator of Toll-like receptor signaling. Cell Mol Immunol14:107–117. doi:10.1038/cmi.2016.32.
    OpenUrlCrossRef
  93. 93.↵
    1. Ramakrishnan P,
    2. Baltimore D
    . 2011. Sam68 is required for both NF-κB activation and apoptosis signaling by the TNF receptor. Mol Cell43:167–179. doi:10.1016/j.molcel.2011.05.007.
    OpenUrlCrossRefPubMedWeb of Science
  94. 94.↵
    1. Zhang H,
    2. Song L,
    3. Cong H,
    4. Tien P
    . 2015. Nuclear protein Sam68 interacts with the enterovirus 71 internal ribosome entry site and positively regulates viral protein translation. J Virol89:10031–10043. doi:10.1128/JVI.01677-15.
    OpenUrlAbstract/FREE Full Text
  95. 95.↵
    1. Lawrence P,
    2. Schafer EA,
    3. Rieder E
    . 2012. The nuclear protein Sam68 is cleaved by the FMDV 3C protease redistributing Sam68 to the cytoplasm during FMDV infection of host cells. Virology425:40–52. doi:10.1016/j.virol.2011.12.019.
    OpenUrlCrossRefPubMed
  96. 96.↵
    1. McBride AE,
    2. Schlegel A,
    3. Kirkegaard K
    . 1996. Human protein Sam68 relocalization and interaction with poliovirus RNA polymerase in infected cells. Proc Natl Acad Sci U S A93:2296–2301. doi:10.1073/pnas.93.6.2296.
    OpenUrlAbstract/FREE Full Text
  97. 97.↵
    1. Rai DK,
    2. Lawrence P,
    3. Kloc A,
    4. Schafer E,
    5. Rieder E
    . 2015. Analysis of the interaction between host factor Sam68 and viral elements during foot-and-mouth disease virus infections. Virol J12:224. doi:10.1186/s12985-015-0452-8.
    OpenUrlCrossRef
  98. 98.↵
    1. Piotrowska J,
    2. Hansen SJ,
    3. Park N,
    4. Jamka K,
    5. Sarnow P,
    6. Gustin KE
    . 2010. Stable formation of compositionally unique stress granules in virus-infected cells. J Virol84:3654–3665. doi:10.1128/JVI.01320-09.
    OpenUrlAbstract/FREE Full Text
  99. 99.↵
    1. Wang Q,
    2. Nagarkar DR,
    3. Bowman ER,
    4. Schneider D,
    5. Gosangi B,
    6. Lei J,
    7. Zhao Y,
    8. McHenry CL,
    9. Burgens RV,
    10. Miller DJ,
    11. Sajjan U,
    12. Hershenson MB
    . 2009. Role of double-stranded RNA pattern recognition receptors in rhinovirus-induced airway epithelial cell responses. J Immunol183:6989–6997. doi:10.4049/jimmunol.0901386.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top
Download PDF
Citation Tools
Picornaviruses and Apoptosis: Subversion of Cell Death
Sarah N. Croft, Erin J. Walker, Reena Ghildyal
mBio Sep 2017, 8 (5) e01009-17; DOI: 10.1128/mBio.01009-17

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this mBio article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Picornaviruses and Apoptosis: Subversion of Cell Death
(Your Name) has forwarded a page to you from mBio
(Your Name) thought you would be interested in this article in mBio.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Picornaviruses and Apoptosis: Subversion of Cell Death
Sarah N. Croft, Erin J. Walker, Reena Ghildyal
mBio Sep 2017, 8 (5) e01009-17; DOI: 10.1128/mBio.01009-17
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • PICORNAVIRUSES
    • APOPTOSIS
    • TOLL-LIKE RECEPTORS IN APOPTOSIS
    • VIRAL RNA SENSORS IN APOPTOSIS
    • INTRINSIC APOPTOSIS
    • EXTRINSIC AND INTRINSIC APOPTOSIS CROSS TALK
    • DISRUPTION OF APOPTOTIC PATHWAYS BY PICORNAVIRUSES
    • CONCLUSION
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

apoptosis
host-pathogen interactions
Picornaviridae
Picornaviridae Infections
apoptosis
innate immunity
picornavirus
proteases
virus-host interactions

Related Articles

Cited By...

About

  • About mBio
  • Editor in Chief
  • Board of Editors
  • AAM Fellows
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Author Warranty
  • Article Types
  • Ethics
  • Contact Us

Follow #mBio

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Online ISSN: 2150-7511